Torrent Historical Cash Flow

TORNTPHARM   3,504  20.50  0.58%   
Analysis of Torrent Pharmaceuticals cash flow over time is an excellent tool to project Torrent Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 11.4 B or Capital Expenditures of 3.7 B as it is a great indicator of Torrent Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Torrent Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Torrent Pharmaceuticals is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Torrent Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Torrent balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Torrent's non-liquid assets can be easily converted into cash.

Torrent Pharmaceuticals Cash Flow Chart

As of now, Torrent Pharmaceuticals' Dividends Paid is increasing as compared to previous years. The Torrent Pharmaceuticals' current Total Cash From Operating Activities is estimated to increase to about 27.1 B, while Change To Inventory is forecasted to increase to (2.5 B).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Torrent Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Torrent Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Torrent Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Torrent Pharmaceuticals Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Torrent Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Torrent Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
As of now, Torrent Pharmaceuticals' Dividends Paid is increasing as compared to previous years. The Torrent Pharmaceuticals' current Total Cash From Operating Activities is estimated to increase to about 27.1 B, while Change To Inventory is forecasted to increase to (2.5 B).
 2022 2023 2024 2025 (projected)
Capital Expenditures5.7B4.3B6.1B3.7B
Dividends Paid8.6B10.2B10.8B11.4B

Torrent Pharmaceuticals cash flow statement Correlations

0.260.090.22-0.440.080.21-0.15-0.09-0.21-0.22-0.26-0.37-0.180.25-0.31
0.260.170.84-0.32-0.330.00.00.150.52-0.40.14-0.04-0.29-0.110.3
0.090.170.3-0.10.80.440.270.770.130.370.49-0.34-0.660.84-0.63
0.220.840.3-0.24-0.15-0.130.210.260.5-0.090.32-0.12-0.270.070.19
-0.44-0.32-0.1-0.240.02-0.260.50.250.610.080.060.320.41-0.170.09
0.08-0.330.8-0.150.020.530.390.53-0.180.450.41-0.31-0.490.86-0.82
0.210.00.44-0.13-0.260.53-0.06-0.06-0.230.050.090.17-0.280.55-0.4
-0.150.00.270.210.50.39-0.060.490.440.210.26-0.190.20.3-0.18
-0.090.150.770.260.250.53-0.060.490.350.270.39-0.41-0.380.53-0.4
-0.210.520.130.50.61-0.18-0.230.440.35-0.160.220.230.07-0.150.27
-0.22-0.40.37-0.090.080.450.050.210.27-0.160.22-0.2-0.250.52-0.42
-0.260.140.490.320.060.410.090.260.390.220.22-0.01-0.510.23-0.49
-0.37-0.04-0.34-0.120.32-0.310.17-0.19-0.410.23-0.2-0.010.25-0.420.48
-0.18-0.29-0.66-0.270.41-0.49-0.280.2-0.380.07-0.25-0.510.25-0.510.5
0.25-0.110.840.07-0.170.860.550.30.53-0.150.520.23-0.42-0.51-0.68
-0.310.3-0.630.190.09-0.82-0.4-0.18-0.40.27-0.42-0.490.480.5-0.68
Click cells to compare fundamentals

Torrent Pharmaceuticals Account Relationship Matchups

Torrent Pharmaceuticals cash flow statement Accounts

202020212022202320242025 (projected)
Change To Inventory(5.3B)2.2B2.6B(490M)(2.6B)(2.5B)
Change In Cash(892.6M)(1.7B)1.1B3.3B(2.6B)(2.5B)
Free Cash Flow16.8B16.0B17.9B28.3B19.7B20.7B
Change In Working Capital(3.4B)(3.5B)(180M)45.3M(2.0B)(1.9B)
Begin Period Cash Flow6.6B5.7B4.0B5.1B8.4B6.2B
Total Cashflows From Investing Activities(4.5B)(2.0B)(24.2B)(1.7B)(5.4B)(5.7B)
Other Cashflows From Financing Activities1.2B(711.8M)19.1B(3.9B)(6.6B)(6.3B)
Depreciation6.6B6.6B7.1B8.0B8.0B8.3B
Other Non Cash Items1.6B2.7B(1.7B)8.1B820M861M
Dividends Paid3.4B6.8B8.6B10.2B10.8B11.4B
Capital Expenditures3.4B2.0B5.7B4.3B6.1B3.7B
Total Cash From Operating Activities20.1B18.0B23.7B32.7B25.9B27.1B
Net Income15.3B12.3B18.5B16.6B19.1B9.6B
Total Cash From Financing Activities(16.6B)(17.8B)770M(27.8B)(23.0B)(21.8B)
End Period Cash Flow5.7B4.0B5.1B8.4B5.7B6.7B
Other Cashflows From Investing Activities52.5M72.4M(18.4B)1.5B710M745.5M
Change To Account Receivables652.1M(1.1B)(2.9B)780M170M178.5M
Investments(1.2B)(80.9M)(24.2B)(1.7B)(5.4B)(5.1B)
Net Borrowings(5.0B)(3.5B)(9.6B)(8.5B)(7.6B)(7.2B)
Change To Netincome6.5B1.0B4.4B7.2B8.2B8.6B
Change To Liabilities1.6B51.9M1.3B(4.6B)(4.1B)(3.9B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Torrent Stock

The Cash Flow Statement is a financial statement that shows how changes in Torrent balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Torrent's non-liquid assets can be easily converted into cash.